Xiang Chen1, Xiaobo Li1, Jun-Jie Zhang1, Yaling Han2, Jing Kan1, Lianglong Chen3, Chunguang Qiu4, Teguh Santoso5, Chootopol Paiboon6, Tak W Kwan7, Imad Sheiban8, Martin B Leon9, Gregg W Stone10, Shao-Liang Chen11. 1. Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. 2. Division of Cardiology, Shenyang Northen Hospital, Shenyang, China. 3. Division of Cardiology, United Hospital, Fujian Medical University, Fuzhou, China. 4. Division of Cardiology, Zhengzhou University First Hospital, Zhengzhou, China. 5. Division of Cardiology, Medistra Hospital, University of Indonesia Medical School, Jakarta, Indonesia. 6. Division of Cardiology, Bangkok General Hospital, Bangkok, Thailand. 7. Division of Cardiology, Beth Israel Hospital, New York, New York. 8. Division of Cardiology, Pederzoli Hospital-Peschiera del Garda, Verona, Italy. 9. Division of Cardiology, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York. 10. Division of Cardiology, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York. Electronic address: gs2184@columbia.edu. 11. Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China; Key Laboratory of Cardiovascular and Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, China. Electronic address: chmengx@126.com.
Abstract
OBJECTIVES: The present study aimed to investigate the difference in target lesion failure (TLF) at 3 years after double kissing (DK) crush stenting versus provisional stenting (PS) for unprotected left main distal bifurcation (UPLMb) lesions. BACKGROUND: The multicenter and randomized DKCRUSH-V (Double Kissing Crush versus Provisional Stenting for Left Main Distal Bifurcation Lesions: The DKCRUSH-V Randomized Trial) study showed fewer 1-year TLF after DK crush for UPLMb lesions compared with PS. The study reports the 3-year clinical outcome of the DKCRUSH-V study. METHODS: A total of 482 patients with UPLMb lesions who were randomly assigned to either the DK crush group (DK group) or PS group in the DKCRUSH-V study were followed for 3 years. The primary endpoint was the occurrence of a TLF at 3 years. Stent thrombosis (ST) was the safety endpoint. Patients were classified by lesion's complexity and NERS (New Risk Stratification) II or SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) score. RESULTS: At 3 years, TLF occurred in 41 (16.9%) patients in the PS group and in 20 (8.3%) patients in the DK group (p = 0.005), mainly driven by increased target vessel myocardial infarction (5.8% vs. 1.7%; p = 0.017) and target lesion revascularization (10.3% vs. 5.0%; p = 0.029). Definite or probable ST rate at 3 years was 4.1% in the PS group and 0.4% in the DK group (p = 0.006). Notably, DK crush was associated with a significant reduction in both primary and secondary endpoints for patients with complex lesions or at high risk. CONCLUSIONS:Provisional stenting for UPLMb lesions was associated with significantly increased rates of TLF and ST over 3 years of follow-up. Further randomized study is warranted to confirm the benefits of DK crush stenting for complex UPLMb lesions. (Double Kissing and Double Crush versus Provisional T Stenting Technique for the Treatment of Unprotected Distal Left Main True Bifurcation Lesions: A Randomized, International, Multi-center Clinical Trial; ChiCTR-TRC-11001213).
RCT Entities:
OBJECTIVES: The present study aimed to investigate the difference in target lesion failure (TLF) at 3 years after double kissing (DK) crush stenting versus provisional stenting (PS) for unprotected left main distal bifurcation (UPLMb) lesions. BACKGROUND: The multicenter and randomized DKCRUSH-V (Double Kissing Crush versus Provisional Stenting for Left Main Distal Bifurcation Lesions: The DKCRUSH-V Randomized Trial) study showed fewer 1-year TLF after DK crush for UPLMb lesions compared with PS. The study reports the 3-year clinical outcome of the DKCRUSH-V study. METHODS: A total of 482 patients with UPLMb lesions who were randomly assigned to either the DK crush group (DK group) or PS group in the DKCRUSH-V study were followed for 3 years. The primary endpoint was the occurrence of a TLF at 3 years. Stent thrombosis (ST) was the safety endpoint. Patients were classified by lesion's complexity and NERS (New Risk Stratification) II or SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) score. RESULTS: At 3 years, TLF occurred in 41 (16.9%) patients in the PS group and in 20 (8.3%) patients in the DK group (p = 0.005), mainly driven by increased target vessel myocardial infarction (5.8% vs. 1.7%; p = 0.017) and target lesion revascularization (10.3% vs. 5.0%; p = 0.029). Definite or probable ST rate at 3 years was 4.1% in the PS group and 0.4% in the DK group (p = 0.006). Notably, DK crush was associated with a significant reduction in both primary and secondary endpoints for patients with complex lesions or at high risk. CONCLUSIONS: Provisional stenting for UPLMb lesions was associated with significantly increased rates of TLF and ST over 3 years of follow-up. Further randomized study is warranted to confirm the benefits of DK crush stenting for complex UPLMb lesions. (Double Kissing and Double Crush versus Provisional T Stenting Technique for the Treatment of Unprotected Distal Left Main True Bifurcation Lesions: A Randomized, International, Multi-center Clinical Trial; ChiCTR-TRC-11001213).
Authors: Moman A Mohammad; Jonas Persson; Sergio Buccheri; Jacob Odenstedt; Giovanna Sarno; Oskar Angerås; Sebastian Völz; Tim Tödt; Matthias Götberg; Nazim Isma; Troels Yndigegn; Patrik Tydén; Dimitrios Venetsanos; Mats Birgander; Göran K Olivecrona Journal: J Am Heart Assoc Date: 2022-03-30 Impact factor: 6.106
Authors: William T Peverill; Alexander Incani; Stephen G Worthley; Yash Singbal; Paul J Garrahy; Andrew B McCann; Stephen V Cox; Peter T Moore; Richard Y Y Lim; Taufik Fetahovic; Gerard W Connors; Cindy Hall; Charmaine Sieg; Anthony C Camuglia Journal: Int J Cardiol Heart Vasc Date: 2020-09-25
Authors: Francesco Burzotta; Jens Flensted Lassen; Thierry Lefèvre; Adrian P Banning; Yiannis S Chatzizisis; Thomas William Johnson; Miroslaw Ferenc; Sudhir Rathore; Remo Albiero; Manuel Pan; Olivier Darremont; David Hildick-Smith; Alaide Chieffo; Marco Zimarino; Yves Louvard; Goran Stankovic Journal: EuroIntervention Date: 2021-03-19 Impact factor: 6.534
Authors: Thomas F Valenzuela; Francesco Burzotta; Tinen L Iles; Jens F Lassen; Paul A Iaizzo Journal: Int J Cardiovasc Imaging Date: 2021-05-16 Impact factor: 2.357